Takeda Pharmaceutical Company Limited
City | Country | Type | Project Area | Classification | Date |
---|---|---|---|---|---|
Hikari | Japan | Drugs | Drug Quality Assurance | VAI | 11/06/23 |
Hikari | Japan | 05/24/23 | |||
Hikari | Japan | Drugs | Drug Quality Assurance | VAI | 07/19/21 |
Hikari | Japan | Drugs | Drug Quality Assurance | OAI | 11/26/19 |
Hikari | Japan | Drugs | Drug Quality Assurance | NAI | 11/07/17 |
Hikari | Japan | Drugs | Drug Quality Assurance | VAI | 10/30/15 |
Hikari | Japan | Drugs | Drug Quality Assurance | VAI | 09/18/13 |
Hikari | Japan | 09/18/13 | |||
Hikari | Japan | 07/20/12 | |||
Hikari | Japan | 09/29/11 | |||
Hikari | Japan | 09/24/10 | |||
Hikari | Japan | 08/26/08 | |||
Hikari | Japan | 10/24/03 | |||
Hikari | Japan | 02/09/01 |
Reference: FDA Data Dashboard
Note: There are 14 inspections, but 6 FDA Data Dashboard records. This is because the agency enumerates inspection-classifications, not inspection events.